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Abstract
Members of the Ty3-Gypsy retrotransposon family are rare in mammalian genomes despite their abundance in
invertebrates and some vertebrates. These elements contain a gag-pol-like structure characteristic of retroviruses but have
lost their ability to retrotranspose into the mammalian genome and are thought to be inactive relics of ancient
retrotransposition events. One of these retrotransposon-like elements, PEG11 (also called RTL1) is located at the distal end of
ovine chromosome 18 within an imprinted gene cluster that is highly conserved in placental mammals. The region contains
several conserved imprinted genes including BEGAIN, DLK1, DAT, GTL2 (MEG3), PEG11 (RTL1), PEG11as, MEG8, MIRG and DIO3.
An intergenic point mutation between DLK1 and GTL2 causes muscle hypertrophy in callipyge sheep and is associated with
large changes in expression of the genes linked in cis between DLK1 and MEG8. It has been suggested that over-expression
of DLK1 is the effector of the callipyge phenotype; however, PEG11 gene expression is also strongly correlated with the
emergence of the muscling phenotype as a function of genotype, muscle type and developmental stage. To date, there has
been no direct evidence that PEG11 encodes a protein, especially as its anti-sense transcript (PEG11as) contains six miRNA
that cause cleavage of the PEG11 transcript. Using immunological and mass spectrometry approaches we have directly
identified the full-length PEG11 protein from postnatal nuclear preparations of callipyge skeletal muscle and conclude that
its over-expression may be involved in inducing muscle hypertrophy. The developmental expression pattern of the PEG11
gene is consistent with the callipyge mutation causing recapitulation of the normal fetal-like gene expression program
during postnatal development. Analysis of the PEG11 sequence indicates strong conservation of the regions encoding the
antisense microRNA and in at least two cases these correspond with structural or functional domains of the protein
suggesting co-evolution of the sense and antisense genes.
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Introduction
More than 45% of the mammalian genome is composed of
repetitive elements, representing DNA transposons, long terminal
repeat (LTR) retrotransposons, LINEs (Long Interspersed Nuclear
Elements) and SINEs (Short Interspersed Nuclear Elements) [1].
Many of these are genetic relics of ancient transposition events and
are generally thought to be inactive due to accumulated mutations
and silencing by epigenetic genome ‘defense’ mechanisms,
particularly DNA methylation [2]. However, in some instances
these repetitive elements may influence the transcription of
adjacent protein encoding genes [3]. DNA methylation is also
involved in the regulation of genomic imprinting, causing genes to
be mono-allelically expressed in a parent of origin specific manner;
hence a relationship between the retroelements and the evolution
of genomic imprinting mechanisms has been suggested [4,5,6,7].
Ty3-Gypsy retrotransposons are rare in mammalian genomes
despite their high abundance in some invertebrate and non-
mammalian vertebrate classes [7]. A small family of nine
mammalian genes with homology to the Ty3-Gypsy long terminal
repeat retrotransposon Sushi-ichi from fugu has been identified
[7,8,9]. These elements contain the gag-pol-like structure
common to retroviruses, but have lost their long terminal repeats
and presumably the ability to autonomously retrotranspose into
the genome. Interestingly, two autosomal members of this gene
family, paternally expressed gene 10 (PEG10) and paternally
expressed gene 11 (PEG11; otherwise known as RTL1) are
imprinted, being expressed only from the paternal chromosome,
while five members map to the X chromosome [7]. The
conservation of PEG11 in placental mammals and its absence
from syntenic chromosomal regions of nonplacental mammals
suggests that during evolution the newly retrotransposed gene was
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co-opted for distinct functional roles within the placental
mammals [7,10].
PEG11 is present in a conserved imprinted gene cluster
spanning ,1 Mbp which is located in sheep at the distal end of
chromosome 18. The cluster contains at least nine imprinted genes
including BEGAIN, DLK1, DAT, MEG3 (GTL2), PEG11 (RTL1),
PEG11as, MEG8, MIRG and DIO3 [5,11,12,13,14,15]. This region
controls the inheritance of the callipyge phenotype in sheep, which
is characterised by postnatal muscular hypertrophy primarily
localized to the hindquarters [12,16,17,18]. The callipyge
mutation is an A/G transition in a long range regulatory element
located between DLK1 and GTL2 [11,19,20]. Unusually, the
phenotype is only expressed by heterozygous lambs that inherit the
mutation from their sire (i.e. the NCpat genotype). This non-
Mendelian parent of origin inheritance pattern has been termed
polar over-dominance [17,21,22].
The callipyge muscle hypertrophy phenotype is associated with
enhanced expression of a core group of these imprinted genes
linked in cis with the mutation. These include: (i) paternally
expressed DLK1 (DAT is probably an alternatively polyadenylated
transcript of DLK1 [13]) and PEG11, and; (ii) the maternally
expressed non-coding genes, GTL2, PEG11as and MEG8
[11,23,24,25,26,27,28]. The paternal influence of the mutation
on the muscle phenotype indicates that a paternally expressed
gene is likely to be causal. Substantial evidence implicates DLK1 as
the effector of the phenotype and indeed DLK1 is the only
authenticated protein-encoding gene amongst these six genes
[25,28,29,30]. However, PEG11 mRNA expression is also strongly
up-regulated in affected muscles of paternal heterozygotes
[23,27,31] suggesting that it also could be a contributor to the
muscle hypertrophy in callipyge sheep.
Until now there has been little or no evidence that the PEG11
retrotransposon-like transcript produces a protein, especially since
the anti-sense transcript (PEG11as) contains six miRNA that have
been shown to cause RISC-mediated cleavage of the PEG11 sense
transcript [31]. However, the paternally expressed ovine PEG11
gene contains a conserved long open reading frame suggesting that
it does produce a protein. The orthologous mouse RTL1 protein
has been localised in murine placenta by immunohistochemistry
[32] although there were no details of the nature of the detected
protein. We now report the direct identification of the full length
ovine PEG11 protein isolated from callipyge skeletal muscle and
demonstrate that its expression is substantially increased in the
callipyge NCpat genotype.
Results
Organization of the imprinted genes located at the
telomeric end of ovine chromosome 18
Figure 1(a) shows a diagrammatic representation of the
organization of imprinted genes located towards the telomeric
end of ovine chromosome 18. The genes that showed altered
expression as a result of the callipyge mutation are colored either
blue or pink for paternally and maternally expressed transcripts,
respectively. All core maternally expressed genes produce
noncoding RNA. Only DLK1 encodes an authenticated protein.
The PEG11 sequence is confined to a single exon with a 3,999 bp
open reading frame potentially encoding a 151,028 Da protein.
While there are some differences in the length of the PEG11 gene
in other species, notably rodents, all placental mammalian
orthologs have maintained the single long open reading frame
suggesting that a protein is produced. Figure 1(b) shows the
relationship between PEG11 and PEG11as. The 39 and 59
boundaries of the non-coding PEG11as transcript are undefined
although it is known that the transcript includes the region
corresponding to the PEG11 transcript [11,23,31]. PEG11as also
encodes six miRNA, mir-431, mir-433 (consisting of mir-433-5p
and mir-433-3p i.e. both stem loops produce a functional miRNA),
mir-127, mir-432 and mir-136 [31].
Over-expression of PEG11 mRNA in callipyge
semimembranosus and longissimus dorsi skeletal muscle
during postnatal development
Gene expression analysis was used to measure the expression of
PEG11 in semimembranosus (SM) skeletal muscle from 12 week-old
animals (i.e. 230 days post-conception; birth was at day 147)
Figure 1. Diagrammatic representation of the organization of imprinted genes located at the telomeric end of ovine chromosome
18. (A) Representation of the approximate 1 Mbp region from BEGAIN to DIO3. The core imprinted genes affected by the callipyge mutation are
colored while imprinted genes unaffected by the mutation are shown in grey. Paternally expressed genes are shaded blue and maternally expressed
genes are shaded pink. The direction of transcription of each gene is indicated by the arrow in the gene symbol. Introns are not shown. The red
asterisk denotes the position of the callipyge point mutation (CLPG). The precise lengths of the maternally expressed genes, which all produce non-
coding RNAs, are unclear. The diagram is based on that deduced by [53] supplemented with annotation for a miRNA cluster (MIRG) deduced by
comparative sequence analyses with the orthologous murine and human sequence regions. (B) Representations of the PEG11 and PEG11as genes. A
large black arrow denotes the direction of transcription of each gene. Small arrows show the relative positions of PCR primers. The region of PEG11
expressed as a recombinant protein (rPEG11) is also shown. The precise length of the PEG11as gene is unclear but it extends beyond the PEG11 gene
in both directions (represented by broken lines).
doi:10.1371/journal.pone.0008638.g001
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(Figure 2(a)). The SM muscle at this developmental time was
known to undergo hypertrophy in callipyge (NCpat) compared with
wild type (NN) sheep [12,16,17,18]. Correspondingly, there was
significantly enhanced expression (45 fold increase; P,0.001) of
PEG11 in the samples from NCpat sheep compared with wild type
sheep. Some individuals of the same genotype were apparently
more affected than others e.g. animal 7 in the NCpat group.
Developmental profiles for the expression of PEG11 in
longissimus dorsi (LD) skeletal muscle samples from fetal, newborn
and adult sheep for the genotypes NCpat and NN are shown in
Figure 2(b). The LD muscle also undergoes postnatal hypertrophy
in callipyge (NCpat) compared with wild type (NN) sheep
[12,16,17,18]. In the NN genotype PEG11 expression was
relatively high in the fetal samples at 80 and 100 days of
development, declined to a lower level at 120 days of fetal
development and then declined much further in the two postnatal
samples (150 and 230 d). In contrast, for the NCpat genotype
PEG11 expression declined just prior to birth (120 d) but then
maintained a relatively high fetal-like expression level in the
postnatal samples i.e. there were significantly higher levels of
PEG11 expressed in the two postnatal NCpat samples compared to
NN samples at the same stages i.e. 150 d and 230 d. The enhanced
expression of PEG11 in the postnatal samples mirrored the
emergence of the muscle hypertrophy phenotype in callipyge
animals [33].
Identification of PEG11 protein in callipyge
semimembranosus skeletal muscle
For the identification of the PEG11 protein, samples of SM
skeletal muscle were taken from callipyge and wild type sheep at
12 weeks of age (230 d of development) i.e. a stage when there was
enhanced expression of PEG11 mRNA and full expression of the
hypertrophy phenotype in the NCpat genotype. Nuclear protein
fractions were subjected to immunoblotting using an immunoaffi-
nity-purified antibody raised in rabbits to recombinant ovine
PEG11 (rPEG11) corresponding to a 162 amino acid region of the
putative full length protein (see Fig. 1(b)). Figure 3 shows an
immunoblot of SM skeletal muscle samples taken from three wild
type (NN) and two callipyge (NCpat) animals. The band labelled A
was only present in samples from the callipyge paternal
heterozygote genotype (NCpat) but not wild type (NN) samples.
This band corresponded to a protein of 146 kDa, which was
consistent with the predicted size of the PEG11 protein deduced
from its full length amino acid sequence (i.e. 151,028 Da;
pI = 4.86) (ProtParam; http://us.expasy.org/tools). Regions cor-
responding to the immuno-reactive band were excised from SDS-
PAGE gels, washed, and digested with trypsin. The resulting
peptides were recovered and analysed by mass spectrometry. The
weakly stained and diffuse 190 kDa band, designated B, was
independently identified as myosin heavy chain, a prominent
protein in skeletal muscle, using liquid chromatography electro-
spray ionization mass spectrometry/ mass spectrometry (LC-ESI-
MS/MS) (ProtScore .7.5; statistical confidence .97%) (result not
shown). The presence of this protein in one sample was probably
an artefact of the protein fractionation procedure.
Figure 2. Relative expression levels of PEG11/PEG11as mRNA in
wild type (NN) and callipyge (NCpat) genotypes during skeletal
muscle developmental. Expression levels were measured by qRT-
PCR and normalised to RPLPO. (A) PEG11/PEG11as mRNA expression in
SM muscle taken at 12 weeks (230 days post-fertilisation) of age from
four wild-type (NN) (grey) and four callipyge paternal heterozygote
(NCpat) individuals (black). The mean expression values of the four
individuals representing each genotype are illustrated in the inset. The
qRT-PCR assay measured expression of both PEG11 and PEG11as as the
former is wholly contained within the latter. However, the contribution
of PEG11as is relatively minor in these genotypes and thus the assay
primarily measures expression of PEG11 (see Materials and Methods). (B)
PEG11/PEG11as expression in LD muscle during muscle development as
a function of genotype. The samples were taken at 80, 100, 120, 150
and 230 days of development. Birth is at 147 days. The error bars
denote the standard error of mean (n = 4). The asterisks denote
significant (P,0.001) differences in expression levels between the NCpat
(black) and NN (grey) genotypes at each developmental stage.
doi:10.1371/journal.pone.0008638.g002
Figure 3. Immunoblot analysis for PEG11 protein in nuclear
fractions from ovine SM skeletal muscle samples obtained
from different individuals at 12 weeks of age. Nuclear extract
(100 mg) from each muscle sample was separated by SDS-PAGE,
transferred to nitrocellulose and probed with immunoaffinity-purified
rabbit antibody raised to recombinant ovine PEG11 (rPEG11). Lanes 1–3,
nuclear protein fractions from SM muscle obtained from three wild type
(NN) individuals; lanes 4 and 5, two callipyge (NCpat) samples; lane S,
protein size standards. Proteins designated A (,Mr=146,000 Da) and B
(,Mr= 190,000 Da) were identified by mass spectrometry analysis as
PEG11 and myosin heavy chain, respectively.
doi:10.1371/journal.pone.0008638.g003
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Two parallel approaches were undertaken to determine peptide
amino acid sequences from band A. First, liquid chromatography
matrix assisted laser desorption ionization time-of-flight/ time-of-
flight mass spectrometry (LC-MALDI-TOF-TOF) analysis of the
tryptic digest was performed with manual searching and
identification of theoretical PEG11 tryptic peptides. Second, a
targeted analysis using hypothetical multiple reaction monitoring
(MRM) and an MRM-initiated detection and sequencing work-
flow on a linear ion trap mass spectrometer was employed (LC-
ESI-MS/MS). Database searching using ProteinPilotTM (Applied
Biosystems) software was conducted in which a customised
FASTA file was created to include the putative PEG11 protein
sequence. The LC-MALDI-TOF MS/MS analysis detected and
sequenced five peptides while the LC-ESI-MS/MS analysis
detected and sequenced four peptides (Table 1). Two peptides
were identified by both methodologies. All peptides detected using
these dual approaches were derived from ovine PEG11. Figure 4
shows one example spectrum of each approach. The combined
peptide sequences corresponded to 8.2% of the predicted PEG11
amino acid sequence (Fig. 5). This coverage provided unequivocal
identification of the protein. The absence of the full complement of
peptides was probably due to several factors including the inability
to detect some individual peptides by mass spectrometry due to
peptide amino acid composition bias, extremes of peptide length,
and potential post-translational modifications. All peptides were
preceded by and ended in K or R, as expected from the specificity
of trypsin. The identification of proximal N-terminal and C-
terminal peptides indicated that the PEG11 protein was likely to
be full length or near full length in sequence, as predicted from its
size upon immunoblotting. Attempts at Edman sequencing using a
Procise Protein Sequencer to identify the N-terminus were
unsuccessful suggesting that it was chemically modified. The N-
terminus was assigned to the sequence commencing MIEP as a
consequence of predicted mRNA sequence conservation in regions
39 to this putative ATG start site and poor conservation in the
region 59 to this site.
Impact of antisense miRNA on the coding potential of
PEG11
Figure 6 shows regions of localized conservation in the available
mammalian PEG11 nucleotide sequences (except rat and mouse),
which were measured using the UCSC PhastCons Conserved
Elements Vertebrate Multiz Alignment and Conservation tool
[34]. Also shown are the relative positions of six conserved miRNA
present in the PEG11as gene i.e. mir-431, mir-433 (consisting of
mir-433-5p and mir-433-3p i.e. both stem loops produce a
functional miRNA), mir-127, mir-432 and mir-136. The mouse
and rat sequences were not included as they additionally each
contain two large non-homologous insertions which make
alignments problematic. The regions of high conservation in the
PEG11 gene corresponded precisely with the antisense miRNA.
Thus, there were strong constraints imposed on the PEG11
protein sequence caused by regions encoding conserved miRNA
antisense to the PEG11 gene. Examination of the rates of
nonsynonymous (dN) and synonymous (dS) substitutions using all
available mammalian full length PEG11 sequences (except rat and
mouse) revealed that dN/dS values were significantly less than one
thereby demonstrating that purifying selection was operating
across the whole of the gene [10] (and our unpublished results). A
similar but more focused examination of each PEG11 region
corresponding with each miRNA was confounded by the
assumption in these analyses that synonymous substitutions in
these regions represent neutral evolution. This was clearly not the
case due to the conservation of miRNA sequence in the antisense
strand. To overcome this limitation an average value of dS over
the whole of the gene was used for analysis of each region
corresponding to the antisense miRNA. The ratio of dN (specific to
the PEG11 region defined by each antisense miRNA) to dS
(calculated across the whole of the gene) was calculated for all six
ovine miRNA regions. In almost all cases, dN/dS values were
considerably less than the value calculated for the whole gene
indicating that there was relatively greater purifying selection in
the regions containing antisense miRNA compared with the whole
gene (result not shown). The exception was the region corre-
sponding to mir-431 where the value of dN/dS was slightly greater
than one, likely indicating relaxed selective constraint.
Figure 7(a) shows the probabilities of coiled coil formation in
the human, guinea pig, horse and sheep PEG11 protein
sequences. The regions of high probability for coiled coil
formation highlight localised differences between the species.
The peaks were generally in the same relative locations except
that species specific combinations of the peaks occur. Whereas
human had four major peaks, guinea pig had one while the
artiodactyl species, horse and sheep, had two or three,
respectively. The only conserved peak in all four species
corresponded exactly with a region encompassing the conserved
antisense miRNA, mir-431. In this instance the presence of the
conserved antisense miRNA in the PEG11 gene placed
Table 1. Ovine PEG11 peptides detected by mass spectrometry1.
Detection method Peptides Theor. MW (Da) Exp. MW (Da) Dm (Da)
LC-MALDI-MS/MS DALQDDLQR 1072.51 1072.48 0.03
STQGLSIVTHR 1197.65 1197.62 0.03
RPLQHPPTQAEALAR 1683.92 1683.91 0.01
QMESSEGSSETTVETPPGGR 2064.89 2064.89 0.00
ALTDFLAAVSTQALPTLVEASPPSER 2683.41 2683.33 0.08
ESI-LC-MS/MS EMPTSEDAQPLPR 1469.68 1469.03 0.65
STQGLSIVTHR 1197.65 1197.60 0.05
YLENTEEPIMILLNK 1818.94 1819.30 0.36
ALTDFLAAVSTQALPTLVEASPPSER 2683.41 2682.91 0.50
1Data from the seven different peptide fragments identified by LC-MALDI-MS/MS and LC-ESI-MS/MS are tabulated with their corresponding theoretical and
experimental peptide masses (Da), as well as the difference in mass (Dm).
doi:10.1371/journal.pone.0008638.t001
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constraints on the PEG11 protein sequence in this region possibly
implicating the conserved coiled coil structure in the function of
PEG11. Inclusion of the corresponding murine and rat profiles
was problematical as each of these rodent sequences had
insertions of two large repetitive regions (green triangles in
Figure 7(b)) and the sequences and lengths of these regions were
quite different in these two species.
Figure 7(b) shows a diagrammatic representation of the domain
structure of the ovine PEG11 protein based on conserved
structures present in all mammalian sequences. Six structural
domains typical of a retrotransposon were identified i.e. capsid-like
or retrotransposon gag protein domain (PF03732), retroviral
aspartyl protease domain (PF00077), a reverse transcriptase
domain (PF00078), an RNaseH domain (PF00075) and an
Figure 4. Mass spectrometry analyses of two peptides derived from the tryptic digest of protein contained within the PEG11
immuno-reactive region of the SDS-PAGE gel. Seven unique peptides were identified by using two parallel mass spectrometry approaches.
Example product ion ms/ms spectra for peptides identified by each technique are shown. (A) LC-MALDI-MS/MS, and; (B) LC-ES-MS/MS. For each
peptide, the amino acid sequence is tabulated along with the theoretical m/z values corresponding to the y and b ions. The experimentally detected
sequence ions are denoted by bold typeface and grey shading (insets). A selection of the sequence ions is labelled in the ms/ms spectra.
doi:10.1371/journal.pone.0008638.g004
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integrase core domain (PF00665), although only PF03732 and
PF00098 were significant (Expect scores = 6.6e211 and 1.4e25,
respectively; http://pfam.sanger.ac.uk). There was also a zinc
finger knuckle (PF00098) closely associated with the retroviral
aspartyl protease domain. As has been previously reported,
mutations in many of the catalytic sites of the reverse transcriptase,
RNaseH and integrase domains probably inactivated these
activities [10]. These mutations were largely responsible for the
lack of significant Expect scores associated with the pfam protein
domain analysis. However, the capsid-like or retrotransposon gag
protein domain and retroviral aspartyl protease domain largely
maintained essential residues suggesting that they may be
functional [10] (our unpublished results). The immunoblot and
peptide mass spectrometry data, which demonstrated that the
PEG11 protein was full length, suggested that the aspartyl protease
domain was either inactive or did not have autolytic activity.
Notably, there was only one instance where a coding region
corresponding to an antisense miRNA was present within one of
these domains i.e. the RNaseH domain (PF00075). Furthermore,
none of the coiled coil regions was present within any of these
functional domains. The relative positions of the large murine and
rat repetitive insertions are also shown and these also do not
correspond with any of the functional domains.
Discussion
The conservation of a long open reading frame in the PEG11
gene and evidence for purifying selection suggested that it encodes
a protein. The current study has demonstrated that PEG11 is
transcribed and produces a full length 151,028 Da protein in
callipyge skeletal muscle. This is the first definitive demonstration
that this mammalian retrotransposon related gene produces a
corresponding protein. There has been one report, using a mouse
genetic model of RTL1 over-expression, showing perinuclear
immunolocalisation of RTL1 in capillary endothelial cells of the
placenta [32]. Gene targeting of RTL1 combined with paternal or
maternal inheritance of the disrupted allele resulted in loss or over-
expression of RTL1 expression, respectively [32]. Both circum-
Figure 5. Sequence coverage of PEG11 peptides. The peptides sequenced by LC-MALDI-MS/MS and ESI-LC-MS/MS are bolded and underlined.
The combined peptide sequences represented 8.2% of the ovine PEG11 sequence. The putative N-terminus was deduced from the longest open
reading frame of the mRNA sequence in conjunction with the marked DNA sequence conservation transition occurring 59 to the putative initiating
methionine.
doi:10.1371/journal.pone.0008638.g005
Figure 6. Conserved regions of the ovine PEG11 gene correspond with antisense miRNA. The PEG11 open reading frame is shown in blue
while the locations of antisense miRNA (mir-431, mir-433, mir-127, mir-432 and mir-136) are shown in red. The black arrow denotes the direction of
transcription of PEG11. The graph shows the extent of PEG11 gene conservation using the UCSC PhastCons Conserved Elements 17-way Vertebrate
Multiz Alignment and Conservation tool [34].
doi:10.1371/journal.pone.0008638.g006
PEG11 in Callipyge Muscle
PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8638
stances generated placental abnormalities contributing to late-fetal
and /or neonatal lethality phenotypes, respectively.
The expression of PEG11 mRNA was markedly increased (45
fold) in callipyge (NCpat) SM muscle, which correspondingly shows
extreme muscle hypertrophy two to three months after birth
[16,33,35]. The reason why some animals were more affected than
others is not clear but could hint at the existence of modifier genes
or variation in the extent of allele specific imprinting. The over-
expression of PEG11 is associated with the emergence of the
callipyge skeletal muscle hypertrophy phenotype as a function of
genotype, developmental stage and muscle type thereby suggesting
a possible causal role. It has been reported that PEG11 mRNA
expression is also up-regulated in supraspinatus callipyge skeletal
muscle [23,36], a muscle showing no hypertrophy [35], and
therefore it was suggested that PEG11 is not involved in the
induction of muscle hypertrophy in callipyge animals. However,
the up-regulation is relatively small and the absolute values are
much less than in affected muscles. Thus, this observation does not
preclude a potential causal role of PEG11 in the induction of
hypertrophy in callipyge skeletal muscle. Indeed, subtle pheno-
typic effects of the mutation in SS muscle are apparent [37].
There are unusual genetic mechanisms associated with the
inheritance of the callipyge phenotype as the muscle hypertrophy
phenotype is only present in paternal heterozygote animals and
first becomes apparent approximately one month after birth
primarily in muscles located toward the rear of the animal
[12,16,18,22,33]. An elegant genetic model has been proposed to
explain this observation [11]. The model suggests that the balance
between a paternally expressed effector and a maternally
expressed trans-acting repressor dictates the phenotypic outcome.
In the paternal heterozygote the effector is influenced by the
mutation acting in cis causing its marked over-expression relative
Figure 7. Structural domains in the PEG11 protein. (A) Probability of coiled coil formation. All sequences were extracted from the UCSC
genome browser (http://genome.ucsc.edu/). Coiled coils were predicted using Coils and a 14 amino acid window [52]. The relative positions in the
PEG11 protein corresponding with regions encoding antisense miRNA are shown in red. (B) Structural domains common to mammalian PEG11
proteins. The diagram is based on the ovine sequence but is representative of mammalian sequences. Structural domains were identified by
searching the Pfam protein families database [51]. PF03732 (capsid-like or retrotransposon gag protein domain; Expect score = 3.4e211); PF00077
(retroviral aspartyl protease domain; Expect score = 0.33); PF00098 (zinc finger knuckle; Expect score not significant); PF00078 (reverse transcriptase
domain; Expect score = 1.4e25); PF00075 (RNaseH; Expect score not significant) domain; PF00665 (integrase core domain; Expect score not
significant). Mutations to key residues in some of the PEG11 retrotransposon domains have compromised the significance of identification of some
Pfam families, which are often biased in their weightings of catalytic residues. The positions corresponding to regions encoding antisense miRNA are
shown in red. The green triangles denote positions where there are large insertions of repetitive sequence in the murine and rat protein sequences.
The sequence insertions at each site for these two species are not conserved in sequence or length.
doi:10.1371/journal.pone.0008638.g007
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to the maternally expressed repressor. The excess of effector in this
genotype thereby induces the muscle hypertrophy. Conversely, in
the CmatN genotype the mutation acts in cis to increase expression
of the maternally expressed repressor but it has no influence on the
effector which it is not expressed from the wild type paternal allele.
Hence there is no phenotype. In the homozygote (CmatCpat) both
the paternally expressed effector and maternally expressed
repressor are up-regulated but there is no imbalance between
effector and repressor, and therefore no phenotype.
The only two paternally expressed genes in the core of the
imprinted locus in which the mutation lies, and hence potential
effectors of the phenotype, are DLK1 and PEG11. There is
significant evidence suggesting that DLK1 is the effector. First, the
increased expression of DLK1 as a function of genotype,
development, muscle type and muscle fibre type is also strongly
associated with the expression of the hypertrophy phenotype
[11,26,28,36]. Second, DLK1 has been implicated in the control
of cell proliferation and differentiation [38]. Third, transgenic
mice over-expressing DLK1 using a myosin light chain 3F
promoter were characterised by mild skeletal muscle hypertrophy
[29]. However, there is also evidence that is inconsistent with
DLK1 being the effector. First, a murine DLK1 knockout resulted
in obesity but no reported muscling phenotype [39]. Second,
constitutive expression of DLK1 in the murine myogenic cell line
C2C12, which does not express endogenous DLK1, did not affect
the differentiation of these cells into multinucleated myotubes [40].
Third, over-expression of DLK1 (using its endogenous regulatory
elements) in transgenic mice resulted in growth enhancement but
the mice failed to survive early life and showed no signs of muscle
hypertrophy [41]. Thus, the cumulative evidence makes it difficult
to differentiate between DLK1 and PEG11 as the potential
effector of the callipyge skeletal muscle hypertrophy. Indeed, it is
possible, and perhaps even likely, that both proteins may
contribute to the callipyge phenotype. This hypothesis could be
tested using transgenic mice over-expressing both genes in the
same skeletal muscle tissues or by using a muscle cell line
transfected with over-expression constructs for both genes.
The nature of the maternally expressed repressor is unclear
although it is noted that only non-coding RNA are maternally
expressed from the core of this imprinted locus [11,27]. These
maternally expressed non-coding genes are strongly up-regulated
in the CmatN and CmatCpat genotypes, both of which do not show a
muscle hypertrophy phenotype. Thus, the presence of the
callipyge mutation on the maternal allele results in cis-mediated
enhanced expression of these noncoding genes, which could act as
trans-acting repressors of the effector produced by either the CmatN
or CmatCpat genotypes, thereby neutralising the influence of the
effector. The miRNA embedded in the maternally expressed
PEG11as gene cause RISC-mediated cleavage of the PEG11
transcript [31] and hence are ideally placed to be the putative
maternally expressed trans-acting repressor of the paternally
expressed PEG11 effector. It is therefore possible that the mutation
on the paternal allele of the NCpat genotype acting in cis causes up-
regulation of PEG11 expression whilst maintaining only a low wild
type expression level of PEG11as from the maternal chromosome.
This would result in a markedly increased ratio of PEG11 to
PEG11as in the paternal heterozygote and therefore a predomi-
nant influence of PEG11 as the effector of the callipyge phenotype.
In the homozygote, enhanced expression of both PEG11 and
PEG11as would occur through the cis-mediated action of the
mutation; however their ratio may not significantly alter thereby
resulting in little change in the level of PEG11 that is not
potentially bound to miRNA derived from PEG11as. This model
could explain the absence of phenotype in the CmatCpat and CmatN
genotypes and the presence of the phenotype in the paternal
heterozygote.
An alternative mechanism to explain the unusual callipyge genetics
could be that the ,50 miRNA associated with the maternally
expressed gene, MIRG [42], act in an analogous fashion to the
miRNA embedded in PEG11as except that they target the DLK1
transcript. In this case it is hypothesised that DLK1 is the effector of
the phenotype. Indeed, bioinformatics predictions indicate that some
of the MIRG miRNA may target DLK1 [13]. DLK1 is an atypical
Notch-like ligand that is expressed on the surface of cells or present in
a soluble circulating form. One possibility is that the miRNA derived
from MIRG preferentially target DLK1 splicing variants and thereby
change the ratio of the constitutively membrane-bound DLK1 C2
variant to variants that can produce soluble circulating forms of
DLK1, which act in a paracrine like manner. This possibility could
result in a miRNA mediated molecular switch that changes the
nature of signalling mechanisms mediated by DLK1. Definition of
the targeting specificities of the multiple miRNA expressed from the
MIRG gene as well as the nature of DLK1 cellular signalling are
required to substantiate this hypothesis.
The PEG11 gene is only present in placental mammals and it is
suggested that its insertion in an eutherian ancestor was
responsible for the development of imprinting at this locus
probably as a by-product of a genome defence mechanism
protecting against retrotransposon insertions [5]. The conservation
of the PEG11 open reading frame despite the acquisition of
mutations that inactivate most of the retrotransposon activities
suggests that this protein was co-opted for mammalian function. A
murine RTL1 (PEG11) knockout upon paternal transmission in
hemizygous animals results in fetal death which is accompanied by
placental defects specifically involving loss of fetal capillaries at the
fetal-maternal interface [32]. Conversely, over-expression of RTL1
as a result of deficiency of RTL1as upon maternal transmission in
RTL1 knockout mice resulted in placentomegaly and neonatal
lethality. Therefore, it was concluded that during mammalian
evolution RTL1 had acquired unique roles in placentation that
were exquisitely sensitive to RTL1 dose. Genomic imprinting may
have been acquired at this locus to regulate the dose of RTL1
during embryonic development. Remarkably, in callipyge sheep
the gene is strongly up-regulated in the NCpat genotype but only in
select muscles during postnatal development. This up-regulation,
unlike that experimentally induced during murine embryonic and
fetal development, does not compromise animal viability, and thus
dosage effects must not be critical during postnatal development.
The function of PEG11 in normal fetal skeletal muscle is
unclear as is its precise role, if any, in generating muscle
hypertrophy when it is over-expressed in callipyge skeletal muscle.
One possibility is that the retroviral GAG-like domain may
promote cell fusion leading to enhancement of the formation of
multinucleated myotubes and thereby promoting muscle hyper-
trophy. However, the location of PEG11 in the nucleus mitigates
against this role. Another possibility, which is an extension of its
placental role [32], is that PEG11 may be responsible for
increasing capillary growth in skeletal muscle. This would be
consistent with the presumed increased vascular demands of
hypertrophied muscle. The normal postnatal down-regulation of
PEG11 in skeletal muscle is also consistent with a primary role in
late fetal development. The callipyge mutation appears to cause
recapitulation of a fetal-like PEG11 expression profile postnatally,
suggesting that the muscle hypertrophy phenotype is associated
with the inappropriate postnatal extension of the PEG11 function.
The conserved long open reading frame in the PEG11 gene
indicates that there is an evolutionary requirement to maintain the
encoded functional protein domains even though mutations to key
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residues in some of these domains may have inactivated their
catalytic functions. What may be retained is the ability to interact
with other proteins or nucleic acids. The retroviral aspartyl
protease domain has maintained essential catalytic residues [10];
however, the presence of the full-length form of PEG11 in
callipyge skeletal muscle suggests that it has little autolytic activity.
One of the functions of this protease activity in authentic
retrotransposons is to process the retrotransposon polyprotein
into its various functional domains. Further experiments are
required to examine the potential proteolytic activity and identify
protein binding partners of PEG11 to establish its functional roles.
The highly conserved miRNA present in PEG11as place strong
coding sequence constraints on the PEG11 protein encoding gene.
The functional implications of this effect on the PEG11 protein are
unclear as the antisense miRNA generally do not correspond with
the known retrotransposon-like domains or other structural
features. However, there are two exceptions. First, the region of
PEG11 corresponding with that encoding antisense mir-431 is
associated with propensity for coiled coil formation. Whilst coiled
coils are a general feature of the PEG11 protein sequence, the
region corresponding to that encoded by antisense mir-431 is
highly conserved in its propensity for coiled coil formation
suggesting an important function possibly involving protein-
protein interactions. Interestingly, most other regions in the
PEG11 sequence that corresponded with antisense miRNA
showed indications of purifying selection relative to the remainder
of the protein. This indicates that mutations in these regions are
deleterious to evolutionary fitness. However, the antisense mir-431
region in PEG11 showed relaxation of selective constraint perhaps
indicating that coiled coil formation in this region can better
tolerate amino acid substitutions and is of greater biological
importance than the constraining influence of antisense mir-431 in
the coding sequence of PEG11. Second, the mir-433 antisense
sequence corresponded to part of the RNaseH domain (PF00075)
but mutations to its active site residues have probably inactivated
its catalytic function. Thus, the collective impacts of the antisense
miRNA on PEG11 protein activities are unclear. However, it is
likely that there has been co-evolution of PEG11 and PEG11as
genes to accommodate the presence of mir-431 and mir-433 in the
structural and functional features of the PEG11 protein.
The primary role of the miRNA is certainly to directly regulate
PEG11 mRNA by RISC-mediated cleavage of the PEG11 sense
transcript [31]. Thus, a trans-mediated effect of the maternally
expressed miRNA can have considerable impact on a target gene
that is paternally expressed. Presumably this unusual regulatory
architecture is required to regulate gene dosage in a situation
where there is need for an optimal dose, but too much or too little
result in adverse biological outcomes.
In conclusion, an authentic full length PEG11 protein is over-
expressed in callipyge skeletal muscle and this retrotransposon-like
protein may be involved in generating the muscle hypertrophy
characteristic of callipyge sheep.
Materials and Methods
Ethics statement
All animals were reared and euthanased in a humane manner in
accordance with the approved Utah State University Animal Care
and Use Committee protocols.
Biological samples
Skeletal muscle samples were obtained from Dorset/Suffolk/
Rambouillet cross-bred sheep raised at Utah State University.
Matings were conducted to produce offspring comprising wild type
(NN) and callipyge (NCpat) genotypes. The genotypes of all animals
were confirmed by restriction fragment length polymorphism
analysis [19,20]. Samples were taken of semimembranosus (SM)
skeletal muscle from new born lambs 2–3 days after birth (150 d)
and lambs at 12 weeks of age (230 d). Samples of longissimus dorsi
(LD) skeletal muscles were also taken from fetal lambs at 80, 100
and 120 days of gestation, new born lambs 2–3 days after birth
(150 d) and lambs at 12 weeks of age (230 d). Birth is at day 147.
The effects of genotype on the characteristics of these muscles and
gene expression within the muscle have been previously reported
[11,16,17,18,19,20]. All muscles were dissected from the animal
within 15 minutes of euthanasia, weighed and samples collected at
equivalent pre-determined sites before freezing in liquid nitrogen.
RNA isolation and cDNA synthesis
Total RNA was extracted from 4 g of tissue following
pulverisation under liquid nitrogen in Trizol reagent (Invitrogen).
A 100 mg aliquot of each RNA sample was treated with DNase 1
(Ambion) and further purified using an RNeasy Midi Kit (Qiagen)
including a second DNAse 1 on–column treatment to remove any
residual traces of genomic DNA. The RNA was quantified by
spectrophotometric measurements at 260 nm and 280 nm and its
purity verified by the OD260/OD280 ratio (.1.8) and integrity
validated by visualisation on an agarose gel. cDNA synthesis was
undertaken with 5 mg of the purified RNA using MMLV
Superscript III reverse transcriptase (Invitrogen) and an anchored
oligo-T18 primer combined with random hexamers [43]. A number
of controls validated the absence of significant quantities of residual
genomic DNA. First, DNAse 1 treated total RNA was subjected to
PCR using PEG11 primers and no significant expression was
detected (Ct.35). Second, PCR products were generated from the
cDNA using primer pairs specific for nine unrelated genes. These
primers were selected to produce differentially sized amplicons for
genomic DNA and cDNA. In all instances only amplicons
characteristic of cDNAs were amplified.
Quantitative real time RT-PCR (qRT-PCR)
qRT-PCR measurements were performed using the SYBR
green system in an ABI prism 7900 Sequence Detection System
(PE Applied Biosystems, Foster City, CA). Primer pairs were
designed with DS Gene software (ver 1.5) (Accelrys)) using publicly
available ovine and bovine sequence information (NCBI, http://
www.ncbi.nlm.nih.gov/) and the Interactive Bovine In Sili-
co Single Nucleotide Polymorphism (IBISS, http://www.
livestockgenomics.csiro.au/ibiss/) systems (Table 2). A constant
amount of cDNA derived from 10 ng of total RNA was used for
each qRT-PCR measurement and four technical replicates were
performed for each gene. Each qRT-PCR (5 ml total volume)
contained: 2.5 ml of 2x SYBR Green Master Mix (Applied
Biosystems); 0.25 ml of each primer giving a final concentration
of 450 nM each; 1.0 ml water, and; 1.0 ml of a 1/10 dilution of the
cDNA template. Cycling conditions were 40 cycles of 95uC for 15
s and 60uC for 1 min. At the completion of each run, a
dissociation melt curve analysis was performed to ensure the
presence of a single specific amplicon. Each qRT-PCR assay was
validated by amplicon size and sequence. Acidic ribosomal protein
P0 (RPLPO) was used as the reference gene [27,28] following
demonstration that its expression was constant in all samples for
the same input cDNA. Data analyses were performed using Q-
gene qRT-PCR analysis software (Gene Quantification (http://
www.gene-quantification.info/) [44] and results were expressed as
Mean Normalized Expression (MNE) relative to the reference
gene. The efficiency (E) of amplification for each assay was
determined (RPLP0, E = 1.96; PEG11/ PEG11as, E = 1.90) and
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applied to calculation of MNE for each sample. Gene symbols used
in the context of a gene or mRNA are shown in italics while normal
text denotes use in the context of the corresponding protein.
The measurement of the expression of PEG11 mRNA using
qRT-PCR can be complicated by the simultaneous expression of
the antisense transcript, PEG11as, which fully encompasses the
region corresponding to the PEG11 gene [11,23,27]. Due to this
genetic architecture, it was not possible to specifically detect only
PEG11 expression; rather the qRT-PCR assay detected both
PEG11 and PEG11as. An assay specific for PEG11as was developed
in a region not present within the PEG11 transcript. Using this
independent assay it was demonstrated that the up-regulation of
PEG11 greatly predominated over PEG11as expression in affected
skeletal muscle from NCpat sheep [27]. Indeed, when expression of
PEG11as was specifically measured in NCpat SM muscle at birth
(150 d of development), it was expressed 18.4266.33 fold less than
for the assay that measured both PEG11 and PEG11as. This result
indicated that increased expression of PEG11 was strongly
predominant over PEG11as in the NCpat genotype. Thus, the
qRT-PCR assay for PEG11 is a good approximation for PEG11
expression in callipyge samples.
Production of recombinant PEG11
Ovine PEG11 sequence (GenBank accession AF354168) was
employed to design PCR primers for amplification of a region
encoding a 162 amino acid fragment (Fig. 1; Table 2). The reverse
primer also contained sequence encoding a C-terminal Hexa-His
affinity tag. The 524 bp amplicon was cloned into the glutathione
S transferase gene fusion vector pGEX2T (GE Healthcare Bio-
Sciences), via the shuttle vector pGEM-T (Promega). Nucleotide
sequences were confirmed by DNA sequencing (Australian
Genome Research Facility, Brisbane). Ovine recombinant
PEG11 (rPEG11) was expressed from the pGEX2T vector
according to the manufacturer’s instructions (GE Healthcare
Bio-Sciences). The rPEG11, which was initially present in
inclusion bodies, was solubilised in 8 M urea, 100 mM NaH2PO4,
10 mM Tris-HCl pH 8.0, and 5 mM b-mercaptoethanol and
purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity chroma-
tography (Qiagen). All buffers contained Complete EDTA-Free
Protease Inhibitors (Roche) and manipulations were performed at
4uC. The resultant rPEG11 was assessed for purity and
appropriate size using SDS-PAGE. Protein estimations were
determined using the colorimetric bicinchoninic acid (BCA) kit
with BSA as the standard (Pierce).
Antibody production and purification
Antibodies were produced by four intramuscular injections of
rabbits with rPEG11 (0.3 mg/dose) given subcutaneously over a 3
month schedule. The antibody specificity of the serum was
validated by ELISA and immunoblotting using rPEG11 as the
antigen. Antibody was immuno-affinity-purified according to a
standard protocol using rPEG11 as the affinity protein [45] and
then further purified by absorption through a glutathione S
transferase affinity column.
Nuclear preparations from skeletal muscle
Nuclear protein extracts were prepared from SM muscle
samples taken from three NN and two NCpat animals at 12 weeks
of age according to an established protocol [46] with minor
modifications. Briefly, frozen SM muscle was wrapped in
aluminium foil, snap frozen in liquid nitrogen and pulverised
with a hammer. On ice, 4.0 g of the ground tissue was
homogenized with 20 ml of 0.6% nonyl phenoxylpolyethoxyletha-
nol (NP-40), 150 mM NaCl, 10 mM HEPES (pH 7.9), 1 mM
EDTA, 0.5 mM PMSF and cellular debris pelleted by centrifu-
gation (4006g, 30 s, 4oC). The supernatant containing intact
nuclei was transferred to 40 ml centrifuge tubes, incubated on ice
for 5 min, and centrifuged (10 min, 7006g, 4oC). The nuclei
preparation was assessed by microscopy (4006magnification)
using Trypan Blue staining. Nuclei stained as blue ovals visible
either by themselves or attached to some remaining myofibril
debris. The nuclear pellet was resuspended in 300 ml of 25%
glycerol, 20 mM HEPES (pH 7.9), 420 mM NaCl, 1.2 mM
MgCl2, 0.2 mM EDTA, 0.5 M DTT, 0.5 mM PMSF and 3 ml of
a Complete Protease Inhibitor tablet (Roche) dissolved in 1 ml of
H2O. The sample was placed on ice for 30 min and centrifuged
(140006g, 1 min, 4oC). The supernatant containing nuclear
proteins was stored at 270uC. Protein quantification was
performed using the NanoDrop ND-1000 spectrophotometer
(Thermo Fischer Scientific).
SDS-PAGE and Immunoblots
SDS-PAGE and immunobloting procedures were performed
essentially according to previous descriptions [43]. Briefly, 100 mg
of purified SM nuclear protein extract from each animal was
added to sample buffer (60 mM Tris-HCl (pH 6.8), 2% SDS, 25%
glycerol and 0.03% bromophenol blue, 5 mM DTT) and resolved
on 6–18% gradient SDS polyacrylamide gels. The gels were then
stained with a modified colloidal Coomassie blue G-250 stain [47].
For immunoblots, the separated proteins were transferred to
Hybond-C nitrocellulose membrane (GE Healthcare Bio-Sciences)
by electroblotting and then the membrane was blocked with TBS
containing 0.1% Tween 20 and 1% (wt/vol) BSA for 30 min at
room temperature. The membrane was incubated for 1 h with
immunoaffinity-purified antibody to rPEG11 (0.1 mg/ml final
concentration), followed by a second incubation with a biotiny-
Table 2. Oligonucleotide sequences.
Gene
(accession number) Forward primer (position) Reverse primer (position)
Amplicon
size (bp)
PEG11/PEG11as (AF354168) 59 cttccactctccctactgcct 39 (151950–151930) 59 gcatccacaggttcccac 39 (151657–151674) 294
PEG11as (AF354168) 59 tcggggctgaggtgggaatctc 39 (154009–154030) 59 cccagctgaagggatcacagcc 39 (154108–154087) 100
rPEG11 (AF354168)1 59 atggatccgctttctactcccgcaacatct 39 (150812–150791) 59 aggaattcctcagtgatggtgatggtgatggaatatctggtccacgggtatc
39 (150327–150348)
524
Acidic ribosomal protein
(AF013214)
59 caaccctgaagtgcttgacat 39 (550–570) 59 aggcagatggatcagcca 39 (776–759) 226
1Flanking sequences for a hexa-His tag and the engineered restrictions sites for BamH1 and EcoR1 are shown in italics.
doi:10.1371/journal.pone.0008638.t002
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lated anti-rabbit IgG antibody (donkey anti-rabbit IgG biotiny-
lated: GE Healthcare Bio-Sciences) (1:7500, 1 h). After washing, a
tertiary incubation was employed using an anti-biotin HRP linked
antibody (Cell Signaling Technologies) (1:2500 dilution, 1 h).
SuperSignal West Pico Chemiluminescent Substrate (Pierce) was
employed to visualise immunoreactive bands. Equal loadings on
the gels were confirmed by colloidal Coomassie staining of a
comparable gel.
Tryptic digests
Following SDS-PAGE, protein regions corresponding to the
immunoreactive bands of interest were excised from the gel, sliced
into quarters and washed in distilled water. The gel pieces were
washed (x3) with 50 ml of 100 mM ammonium bicarbonate and
50% acetoniltrile (ACN) (HPLC grade) in a sonicator for 20 min,
followed by two washes with 50 ml of 40 mM ammonium
bicarbonate. After solvent removal, the gel pieces were dried
under vacuum at 30uC, rehydrated in 30 ml of digestion buffer
(40 mM ammonium bicarbonate, 10% ACN) containing 600 ng
(20 ng/ml) of sequencing grade modified trypsin (Promega) and
incubated for 20 h at 37uC. The sample was centrifuged and the
supernatant collected. The gel pieces were subsequently washed in
40 ml of 30% ACN and 5% formic acid followed by a second wash
containing 60% ACN and 0.1% formic acid. All supernatants
were combined and ACN removed under vacuum at 30uC. The
peptides were reconstituted in 4 ml of 0.1% formic acid for LC-
ESI-MS/MS analysis or 8 ml of 5% formic acid for LC-MALDI-
TOF-TOF analysis. The peptide aliquots were sonicated for
20 min prior to analysis.
LC-MALDI TOF-TOF
Tryptic peptides were fractionated using an Agilent 1100 series
capillary HPLC System (Agilent), mixed with MALDI matrix
(5 mg/ml of a–cyano-4-hydroxycinnamic acid in 50% ACN and
0.1% triofluoroacetic acid in milliQ water), and spotted directly
onto an ABI 4700 OptiTOF sample plate. Briefly, peptide samples
(,8 ml) were injected onto a Vydac 300 A˚ C18 5 mm column
(Vydac) pre-equilibrated with 0.1% formic acid (solvent A).
Solvent B contained 90% ACN and 0.1% formic acid. HPLC
separation of peptides was achieved using a linear gradient from 0
to 50% solvent B for 60 min followed by 50–80% solvent B for
10 min. Fractions were collected at 0.5 min intervals on a 192-
position sample plate and simultaneously mixed with 0.5 ml of
matrix. The samples were then subjected to MALDI MS/MS
analysis using a 4700 Proteomics Analyzer equipped with TOF-
TOF ion optics (Applied Biosystems) and 4000 Explorer version
3.6 analysis software. The instrument was operated in 1 kV
positive ion reflector mode and calibrated with the 4700 Mass
Standards kit (Applied Biosystems) for MS spectra and using Glu-
fibrinopeptide B for MS/MS spectral calibration. The laser power
was set to 5000 for MS and 5500 for MS/MS with CID off. MS
spectra were acquired across the mass range of 850–4000 Da.
MS/MS spectra were acquired manually for precursor ions with
theoretical matches to the masses of tryptic peptides resulting from
the PEG11 protein, with a total accumulation of 5000 laser shots.
LC-ESI-MS/MS
ESI-MS data acquisition was performed using Analyst 1.4.1
software (Applied Biosystems) in the positive ion mode and
multiple-reaction monitoring (MRM)-triggered acquisition of
enhanced product ion (EPI) MS/MS spectra with enhanced
resolution scan for charge state determination and precursor mass
calculation. Chromatographic separation of tryptic peptides was
achieved using an Ultimate 3000 HPLC system (Dionex) with a
Phenomenex Luna C18, 5 mm (3.0 mm6250 mm) column. 10 ml
of the tryptic digest was injected. A linear gradient from 0-40% B
over 40 min was used. The eluent was coupled directly to a 4000
QTRAP (Applied Biosystems) mass spectrometer equipped with a
TurboV source. An ion-spray voltage of 5,300 V was applied and
N2 used as the curtain (value of 25) and collision gas (set to high),
with the heated interface at 150uC. The de-clustering potential
was set at 70 eV and Gas1 and Gas2 were each set to 35 psi. A 75
ms dwell time was used for each MRM transition. Following each
survey scan, the top two precursor ions with multiple charge states
with intensities greater than 150 counts/s were selected for MS/
MS acquisition using a rolling collision energy based on the ions’
observed charge states and masses.
Mass spectrometry data analysis
To facilitate data interpretation, spectra from both mass
spectrometers were searched against the Uniprot database
(URL; downloaded in November 2007) that had been customized
to include the putative PEG11 sequence with ProteinPilot version
2.0 (Applied Biosystems; Paragon search algorithm). The default
search settings used for protein identification were trypsin cleavage
with fixed iodoacetamide modification of cysteine. We report only
protein identifications with a total ProtScore .1.3, which
represents .95% statistical confidence in Protein Pilot. All peptide
matches were manually verified.
Analysis of PEG11 sequence
Sequence alignment was carried out using the ClustalW
program [48]. The mammalian PEG11 coding sequences from
the human, chimpanzee, orangutan, Rhesus Macaca mulatta, mouse,
rat, guinea pig, cat, horse, cow and sheep genomes were extracted
primarily by using the UCSC genome browser [34] as well as
targeted searching of genomic sequence information not repre-
sented on this browser but present in the NCBI database (http://
www.ncbi.nlm.nih.gov/). Conservation of the alignment of the
nucleotide sequences at the 59 ends of the longest open reading
frames was used to identify the putative start codons. The ratio of
nonsynonymous to synonymous substitutions, dN/dS, which is a
measure of variable Darwinian selective pressures, was estimated
by maximum likelihood from the PEG11 coding sequence
alignment using the codeml program from PAMLv4 [49]. Ratios
significantly greater than one indicate positive selection and ratios
significantly less than one indicate purifying selection [50]. The
relative positions of antisense miRNA in the PEG11 nucleotide
sequences and corresponding PEG11 protein sequences were
deduced by using annotated miRNA identified in the UCSC
browser, manual sequence inspection and literature information
[31]. The ratio of non-synonymous change (dN) in these specific
regions to the whole gene value of dS was used to examine the
influence of the antisense miRNA on the PEG11 coding sequence.
Regions of PEG11 sequence conservation in mammals were
extracted using the UCSC PhastCons Conserved Elements
Vertebrate Multiz Alignment and Conservation tool (http://
genome.ucsc.edu/). Functional domains within the PEG11 protein
sequence were identified using the Pfam Protein Families database
(http://pfam.sanger.ac.uk/) [51]. Coiled coils were identified
using Coils (http://www.ch.embnet.org/software/COILS_form.
html) [52].
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